[go: up one dir, main page]

WO2004096098A1 - Prothesis for soft tissue support - Google Patents

Prothesis for soft tissue support Download PDF

Info

Publication number
WO2004096098A1
WO2004096098A1 PCT/IB2004/001311 IB2004001311W WO2004096098A1 WO 2004096098 A1 WO2004096098 A1 WO 2004096098A1 IB 2004001311 W IB2004001311 W IB 2004001311W WO 2004096098 A1 WO2004096098 A1 WO 2004096098A1
Authority
WO
WIPO (PCT)
Prior art keywords
support
breast
layer
tissue
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2004/001311
Other languages
French (fr)
Inventor
Jonathan Hamilton
Gary Pierre Lauryssen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FORMHOLD MEDICAL INVESTMENT HOLDINGS
Original Assignee
FORMHOLD MEDICAL INVESTMENT HOLDINGS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FORMHOLD MEDICAL INVESTMENT HOLDINGS filed Critical FORMHOLD MEDICAL INVESTMENT HOLDINGS
Publication of WO2004096098A1 publication Critical patent/WO2004096098A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/12—Mammary prostheses

Definitions

  • This invention relates to a supporting device for soft tissue, specifically human soft tissue.
  • Surgical procedures include the so-called breast lift procedure, which involves removal of part of the skin of the breast and repositioning the nipple in an attempt to reshape the breasts. This has the disadvantage that it involves scarring of the breast skin, which may remain visible for a long time. It also does not solve the problem of stretching of the supporting tissue, such as skin and ligaments, which will cause the breasts to again sag over time.
  • breast augmentation This involves implanting a liquid filled bladder in the breasts.
  • the liquid is typically either a saline solution or a silicone solution.
  • the main aim of this procedure is to augment the size of the breasts, but this procedure is also used to reshape the breasts.
  • An implant is inserted either between the breast tissue and the pectoral muscle, or inside the pectoral muscle.
  • a problem with breast augmentation is that some of the implants contain silica- compounds, which are difficult to seal inside an implant. There have been incidents where implants have leaked, causing the shape and size of the affected breast to change and causing serious concern about the effect of leaked silica-compound on the patient.
  • the polymer from which the bladder is manufactured is made slightly toxic to the human body. This causes the tissue surrounding the bladder to react to the bladder and encapsulate it, thereby sealing the bladder and any liquid that might leak from it. This is obviously not an ideal solution.
  • the natural and commonly accepted ideal female breast shape includes a slightly inward curve of the tissue above the nipple, a nipple that points slightly upwards, and the skin supporting the breast under the nipple stretching from the nipple to the ribcage with a slight downward curve without substantial contact between the breast skin and the ribcage skin.
  • the implant is inserted between the breast tissue and the pectoral muscle, or splits the pectoral muscle, it is still possible for the breast tissue to sag with age and in effect slide over the implant.
  • a mammalian soft tissue support comprising a biocompatible resilient layer and means to secure the layer subcutaneously to a mamma, the layer formed to adopt a predetermined shaped in use.
  • the layer is further provided for the layer to be made from a synthetic material, and for the layer to be perforated; alternatively for the layer to be made from one of a webbed material, woven material or pressed material.
  • the layer is further provided for the layer to be manufactured from an expanded polytetrafluoroethylene (ePTFE), in particular from an ePTFE material with the trade name Gore-Tex®.
  • ePTFE expanded polytetrafluoroethylene
  • the soft tissue prefferably be a breast
  • the layer predetermined breast shape
  • the mammal to be a human
  • the support to include an upper section and a lower section, and for the upper section to be securable to the skeletal structure of the human above the breast.
  • the lower section is securable to tissue proximate the lower section, and for the tissue to include breast support tissue, specifically ligaments.
  • the support prefferably includes a nipple aperture and a slit from an edge of the layer to the aperture.
  • a further feature of the invention provides for the soft tissue to be a buttock and for the layer to be formed into a predetermined buttock shape.
  • the human is a female.
  • Figures 1 A is an elevation of a support according to the invention
  • Figure 1B is an elevation of the support of Figure 1A with a nipple aperture and slit.
  • Figure 2 is a part sectional view of a human female breast with an implanted support according to the invention
  • Figure 3A is a part sectional view of a human female breast with an augmentation implant between the breast tissue and the pectoral muscle;
  • Figure 3B is a part sectional view of a human female breast with an augmentation implant in the pectoral muscle;
  • Figure 4 is a side view of a human female breast before sagging.
  • Figure 5 is a side view of a human female breast after sagging
  • Figure 6 is a part sectional view of a human female breast with an implanted support according to the invention and an augmentation implant between the breast tissue and the pectoral muscle;
  • FIG. 1A A preferred embodiment of a soft tissue support (1) according to the invention is shown in Figure 1A. It comprises a biocompatible resilient layer (2) that is formed to the shape of human female breast.
  • the support includes means to secure it subcutaneously to a female, which in this embodiment is a tab (3) formed at the upper section (4) of the support (1).
  • the layer is formed of a moulded ePTFE material with the trade name Gore- Tex®. The material is chosen to allow the support (1) to be made to adopt a predetermined shape, in this instance that of a female breast, in use.
  • Figure 1B shows the support of Figure 1A with a nipple aperture (40) and a slit (41) from the edge of the layer (2) to the aperture (40) which allows for implanting the layer (2) subcutaneously without separating the nipple from the breast tissue.
  • the support (1) is secured subcutaneously in the patient's, a human female, breast (9). It (1) is inserted between the skin (7) and the soft breast tissue (8) through an incision in the armpit of the patient.
  • the upper section (4) is secured (10) to the collarbone (11) of the female by stitching the tab (3) around the collarbone (11).
  • the lower section (5) of the support (1 ) is secured to the supporting ligaments (not shown) of the breast (9) through the incision in the armpit and an incision underneath the nipple of the particular breast. The last incision is made along the border of the areola to minimize visibility of the incision.
  • the support (1) Since the support (1) is made to adopt a predetermined ideal breast shape in use it will support the breast tissue (8) into this ideal natural shape.
  • the support (1) is resilient which allows normal movement of the supported breast (8), yet still retains the predetermined shape.
  • Figure 4 shows a breast (20) of a young female that has not yet sagged.
  • the breast (20) is supported by the skin (21) between the nipple (22) and the area (23) around the collarbone (not shown).
  • the breast (20) has a typical ideal shape, which includes a slight inward curve of the upper portion (24) of the breast (20).
  • the lower portion (25) of the breast (20) extends upwards from the ribcage (26) without the lower portion skin (27) resting on the rib cage (26).
  • Figure 5 shows a breast (30) of a female that has started to sag.
  • the breast (30) is still supported by the skin (31) between the nipple (32) and the area (33) around the collarbone (not shown).
  • the breast (30) has a typical sagged shape, which includes a pronounced inward curve of the upper portion (34) of the breast (30).
  • the lower portion (35) of the breast (30) does not extend upward from the ribcage (36), and the lower portion skin (37) rests on the ribcage (36).
  • the invention allows for the shape of a sagged breast to be corrected, as shown in Figure 2, since the support (1) positively shapes the breast (9) to the ideal shape. It lifts the lower section of the breast, which pushes the breast upward. This is done without any substantial increase in the volume of the breast, apart from the slight increase gained from the actual volume of the support.
  • the support (1) with an augmentation implant (12), as is shown in Figure 6.
  • the augmentation implant (12) in the form a liquid filled bladder, is located between the breast tissue (8) and the pectoral muscle (13). This allows for increasing the size of the breast (9A), and at the same time ensures that the enlarged breast (9A) is maintained to the ideal shape.
  • the support functions like a subcutaneous brassiere. It has the advantage that it provides permanent support and shapes the breast to the ideal shape.
  • cows or goats animals that are milked
  • the amount of milk produced per day determines the value of the animal.
  • the cows are therefore bred to attain udders that are as large as possible since this increase the daily milk production.
  • an udder gets too big it may drag on the ground, or tear loose from the supporting tissue. In some instances it then becomes necessary to put the animal down.

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

A mammalian soft tissue support comprising a biocompatible resilient layer and means to secure the layer subcutaneously to a mammal is disclosed. The layer is also formed to adopt a predetermined shape in use. Also disclosed is that the invention may be used on humans and animals, and more specifically female humans. The predetermined shape is either a breast or a buttock or an udder.

Description

PROSTHESIS FOR SOFT TISSUE SUPPORT
FIELD OF THE INVENTION
This invention relates to a supporting device for soft tissue, specifically human soft tissue.
BACKGROUND TO THE INVENTION
Human soft tissue is prone to sagging with age. This is in part due to weakening of supporting tissue, such as ligaments and skin with age. This is an important issue for females since their breast form an important part of their images. A factor that also causes sagging of female breasts is breast-feeding.
There have been various attempts to modify the appearance of breasts, which include the wearing of garments, such as corsets and brassieres, and surgical procedures.
The wearing of garments may produce acceptable results, but it is obviously of no use when not worn. Surgical procedures include the so-called breast lift procedure, which involves removal of part of the skin of the breast and repositioning the nipple in an attempt to reshape the breasts. This has the disadvantage that it involves scarring of the breast skin, which may remain visible for a long time. It also does not solve the problem of stretching of the supporting tissue, such as skin and ligaments, which will cause the breasts to again sag over time.
Another surgical procedure is so-called breast augmentation. This involves implanting a liquid filled bladder in the breasts. The liquid is typically either a saline solution or a silicone solution. The main aim of this procedure is to augment the size of the breasts, but this procedure is also used to reshape the breasts. An implant is inserted either between the breast tissue and the pectoral muscle, or inside the pectoral muscle.
A problem with breast augmentation is that some of the implants contain silica- compounds, which are difficult to seal inside an implant. There have been incidents where implants have leaked, causing the shape and size of the affected breast to change and causing serious concern about the effect of leaked silica-compound on the patient.
To overcome this problem the polymer from which the bladder is manufactured is made slightly toxic to the human body. This causes the tissue surrounding the bladder to react to the bladder and encapsulate it, thereby sealing the bladder and any liquid that might leak from it. This is obviously not an ideal solution.
Another problem with implants is that an implant alone do not necessarily modify the shape of the patient's breasts to a desired shape, but rather just increase the size. The natural and commonly accepted ideal female breast shape includes a slightly inward curve of the tissue above the nipple, a nipple that points slightly upwards, and the skin supporting the breast under the nipple stretching from the nipple to the ribcage with a slight downward curve without substantial contact between the breast skin and the ribcage skin.
With an augmentation implant it is difficult to achieve this shape since the breast tissue is generally pushed forward, which results in at least the curve above the nipple being pushed outward rather than inward. The result is a breast that appears to protrude from the female's chest.
In addition, since the implant is inserted between the breast tissue and the pectoral muscle, or splits the pectoral muscle, it is still possible for the breast tissue to sag with age and in effect slide over the implant.
Another area where men and woman have resorted to implants is in their buttocks. The soft tissue of the buttocks is also prone to sagging with age and people have used implants to counter the effect of this. This has also not been entirely successful.
OBJECT OF THE INVENTION
It is an object of this invention to provide a support for human soft tissue to alleviate at least some of the abovementioned problems.
SUMMARY OF THE INVENTION
In accordance with this invention there is provided a mammalian soft tissue support comprising a biocompatible resilient layer and means to secure the layer subcutaneously to a mamma, the layer formed to adopt a predetermined shaped in use. There is further provided for the layer to be made from a synthetic material, and for the layer to be perforated; alternatively for the layer to be made from one of a webbed material, woven material or pressed material.
There is further provided for the layer to be manufactured from an expanded polytetrafluoroethylene (ePTFE), in particular from an ePTFE material with the trade name Gore-Tex®.
There is further provided for the soft tissue to be a breast, and for the layer to be formed into a predetermined breast shape.
There is further provided for the mammal to be a human, for the support to include an upper section and a lower section, and for the upper section to be securable to the skeletal structure of the human above the breast.
There is further provided for the lower section to be securable to tissue proximate the lower section, and for the tissue to include breast support tissue, specifically ligaments.
There is also provided for the support to include a nipple aperture and a slit from an edge of the layer to the aperture.
A further feature of the invention provides for the soft tissue to be a buttock and for the layer to be formed into a predetermined buttock shape.
There is still further provided for the human to be a female.
BRIEF DESCRIPTION OF THE DRAWINGS
An embodiment of the invention will be described below by way of example only and with reference to the accompanying drawings in which: Figures 1 A is an elevation of a support according to the invention;
Figure 1B is an elevation of the support of Figure 1A with a nipple aperture and slit.
Figure 2 is a part sectional view of a human female breast with an implanted support according to the invention;
Figure 3A is a part sectional view of a human female breast with an augmentation implant between the breast tissue and the pectoral muscle;
Figure 3B is a part sectional view of a human female breast with an augmentation implant in the pectoral muscle;
Figure 4 is a side view of a human female breast before sagging; and
Figure 5 is a side view of a human female breast after sagging;
Figure 6 is a part sectional view of a human female breast with an implanted support according to the invention and an augmentation implant between the breast tissue and the pectoral muscle;
DETAILED DESCRIPTION OF THE DRAWINGS
A preferred embodiment of a soft tissue support (1) according to the invention is shown in Figure 1A. It comprises a biocompatible resilient layer (2) that is formed to the shape of human female breast. The support includes means to secure it subcutaneously to a female, which in this embodiment is a tab (3) formed at the upper section (4) of the support (1). The layer is formed of a moulded ePTFE material with the trade name Gore- Tex®. The material is chosen to allow the support (1) to be made to adopt a predetermined shape, in this instance that of a female breast, in use.
Figure 1B shows the support of Figure 1A with a nipple aperture (40) and a slit (41) from the edge of the layer (2) to the aperture (40) which allows for implanting the layer (2) subcutaneously without separating the nipple from the breast tissue.
As shown in more detail in Figure 2 the support (1) is secured subcutaneously in the patient's, a human female, breast (9). It (1) is inserted between the skin (7) and the soft breast tissue (8) through an incision in the armpit of the patient. The upper section (4) is secured (10) to the collarbone (11) of the female by stitching the tab (3) around the collarbone (11). The lower section (5) of the support (1 ) is secured to the supporting ligaments (not shown) of the breast (9) through the incision in the armpit and an incision underneath the nipple of the particular breast. The last incision is made along the border of the areola to minimize visibility of the incision.
This leaves the support (1) located between the skin (7) and the breast tissue (8), and secured at the upper section (4) and the lower section (5).
Since the support (1) is made to adopt a predetermined ideal breast shape in use it will support the breast tissue (8) into this ideal natural shape. The support (1) is resilient which allows normal movement of the supported breast (8), yet still retains the predetermined shape.
As shown in Figures 3A and 3B conventional augmentation implants allows an implant (14) to be located between the breast tissue (15) and the pectoral muscle (16), or an implant (17) to be located inside the pectoral muscle (19) and for the interface between the pectoral muscle (19) and the breast tissue (18) to be retained.
It is not entirely possible for such an implant to provide a breast with an ideal shape. The reason is simply that the skin between a nipple and respective collarbone naturally supports a breast, and that weakening of this portion of skin causes sagging of the breast. The same applies to ligaments that support the breast.
The natural sagging of breast is shown in Figures 4 and 5. Figure 4 shows a breast (20) of a young female that has not yet sagged. The breast (20) is supported by the skin (21) between the nipple (22) and the area (23) around the collarbone (not shown). The breast (20) has a typical ideal shape, which includes a slight inward curve of the upper portion (24) of the breast (20). The lower portion (25) of the breast (20) extends upwards from the ribcage (26) without the lower portion skin (27) resting on the rib cage (26).
Figure 5 shows a breast (30) of a female that has started to sag. The breast (30) is still supported by the skin (31) between the nipple (32) and the area (33) around the collarbone (not shown). The breast (30) has a typical sagged shape, which includes a pronounced inward curve of the upper portion (34) of the breast (30). The lower portion (35) of the breast (30) does not extend upward from the ribcage (36), and the lower portion skin (37) rests on the ribcage (36).
From Figures 4 and 5 it is clear that implanting an augmentation implant into the breast (30) shown in Figure 5 will not give this breast (30) the ideal shape shown in Figure 4. It will provide the breast (30) will more volume, which will not lift the lower portion (35) of the breast (30). It is possible that the pronounced inward curve of the upper section (34) will be corrected, but this will not lift the lower portion skin (37) from the ribcage (36). It is also possible that the result of an augmentation implant will be to reverse the inward curve to an outward curve (not shown), which also departs from the ideal breast shape.
Therefore, although the volume of the breast will be increased, the shape of the sagged breast (30) will not be corrected by an augmentation implant.
The invention allows for the shape of a sagged breast to be corrected, as shown in Figure 2, since the support (1) positively shapes the breast (9) to the ideal shape. It lifts the lower section of the breast, which pushes the breast upward. This is done without any substantial increase in the volume of the breast, apart from the slight increase gained from the actual volume of the support.
It is also possible to use the support (1) with an augmentation implant (12), as is shown in Figure 6. In this instance the augmentation implant (12), in the form a liquid filled bladder, is located between the breast tissue (8) and the pectoral muscle (13). This allows for increasing the size of the breast (9A), and at the same time ensures that the enlarged breast (9A) is maintained to the ideal shape.
From the above it is clear that the support functions like a subcutaneous brassiere. It has the advantage that it provides permanent support and shapes the breast to the ideal shape.
It will be understood that this is only one embodiment of the invention. It is possible to alter some aspects of the embodiment without departing from the scope of the invention. It is for instance possible to use a support in the shape of a lower section support for a female breast. In this instance the support will be in the shape of a breast cup and will be secured to the breast support tissue around the lower section of the breast. Such a support will function very much like a strapless brassiere. It is also possible to make a support that will function for other body parts, such as buttocks, arms or the like.
It is further possible to make a support that could find application in animals, specifically animals that are milked such as cows or goats. With these animals, especially cows, the amount of milk produced per day determines the value of the animal. The cows are therefore bred to attain udders that are as large as possible since this increase the daily milk production. However, if an udder gets too big it may drag on the ground, or tear loose from the supporting tissue. In some instances it then becomes necessary to put the animal down.
It is also possible to use different techniques to secure the support subcutaneously, which are not described here but falls within the scope of the invention.

Claims

1. A mammalian soft tissue support comprising a biocompatible resilient layer and means to secure the layer subcutaneously to a mammal, and the layer formed to adopt a predetermined shape in use.
2. A support as claimed in claim 1 in which the layer is inert.
3. A support as claimed in claim 1 or 2 in which the soft tissue is a breast and the predetermined shape is a breast shape.
4. A support as claimed in claim 3 in which the mammal is a human, the support includes an upper and a lower section, the upper section is securable to human tissue above the breast, and the lower section is securable to tissue proximate the lower section.
5. A support as claimed in claim 4 in which the upper section is securable to the skeletal structure of the human.
6. A support as claimed in claim 4 or 5 in which the lower section is securable to breast support tissue.
7. A support as claimed in claim 6 in which the lower section is securable to ligaments.
8. A support as claimed in claim 1 to 7 in which the support includes a nipple aperture.
9. A support as claimed in claim 8 in which the support includes a slit from an edge of the layer to the nipple aperture.
10. A support as claimed in claim 1 or 2 in which the in which the soft tissue is a human buttock and the layer is formed to, in use, adopt a predetermined buttock shape.
11. A support as claimed in claim 4 to 10 in which the human is a female.
12. A support as claimed in claim 1 or 2 in which the mammal is an animal and the soft tissue is an udder.
13. A support as claimed in claim 12 in which the animal includes a cow and a goat.
14. A support as claimed in any one of claims 1 to 13 in which the layer is made from a synthetic material.
15. A support as claimed in claim 14 in which the layer is perforated.
16. A support as claimed in claim 14 or 15 in which the layer is made from a webbed material, woven material or pressed material.
17. A support as claimed in claim 14 to 16 in which the layer is manufactured from an expanded polytetrafluoroethylene (ePTFE).
18. A support as claimed in claim 17 in which the layer is manufactured from an expanded polytetrafluoroethylene (ePTFE) with the trade name Gore-
Tex®.
19. A support substantially as herein described with reference to Figures 1, 2 and 6.
PCT/IB2004/001311 2003-04-29 2004-04-29 Prothesis for soft tissue support Ceased WO2004096098A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200303281 2003-04-29
ZA2003/3281 2003-04-29

Publications (1)

Publication Number Publication Date
WO2004096098A1 true WO2004096098A1 (en) 2004-11-11

Family

ID=33419094

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/001311 Ceased WO2004096098A1 (en) 2003-04-29 2004-04-29 Prothesis for soft tissue support

Country Status (1)

Country Link
WO (1) WO2004096098A1 (en)

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009001293A1 (en) * 2007-06-24 2008-12-31 Gary Pierre Lauryssen Human mammary prosthetic support and method of implanting
US7476249B2 (en) 2004-08-06 2009-01-13 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
WO2009039371A1 (en) 2007-09-19 2009-03-26 Ethicon, Inc. Performed support device and method and apparatus for manufacturing the same
US7875074B2 (en) 2007-09-19 2011-01-25 Ethicon, Inc. Naturally contoured, preformed, three dimensional mesh device for breast implant support
WO2011011394A3 (en) * 2009-07-21 2011-03-17 Lifecell Corporation Graft materials for surgical breast procedures
US8007531B2 (en) 2004-08-06 2011-08-30 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
US8101116B2 (en) 2007-09-19 2012-01-24 Ethicon, Inc. Preformed support device and method and apparatus for manufacturing the same
WO2012131222A2 (en) 2011-03-22 2012-10-04 Edouard Pelissier Implantable medical device for the correction of breast ptosis
WO2015006737A1 (en) 2013-07-11 2015-01-15 Tepha, Inc. Absorbable implants for plastic surgery
WO2016172094A1 (en) 2015-04-23 2016-10-27 Tepha, Inc. Absorbable implants for plastic surgery
US9549812B2 (en) 2012-01-13 2017-01-24 Lifecell Corporation Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses
US9585744B2 (en) 2011-03-09 2017-03-07 Tepha, Inc. Systems and methods for mastopexy
US9655715B2 (en) 2013-07-11 2017-05-23 Tepha, Inc. Absorbable implants for plastic surgery
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
USD816221S1 (en) 2017-04-11 2018-04-24 Tepha, Inc. Three dimensional mastopexy implant
USD816220S1 (en) 2017-04-11 2018-04-24 Tepha, Inc. Three dimensional mastopexy implant
US9956072B2 (en) 2012-10-04 2018-05-01 Lifecell Corporation Surgical template and delivery device
US10039633B2 (en) 2012-06-21 2018-08-07 Lifecell Corporation Implantable prosthesis having acellular tissue attachments
USD836778S1 (en) 2015-10-09 2018-12-25 Tepha, Inc. Three dimensional mastopexy implant
US10307237B2 (en) 2015-05-15 2019-06-04 Lifecell Corporation Tissue matrices and methods of treatment
WO2019156870A2 (en) 2018-02-09 2019-08-15 Tepha, Inc. Full contour breast implant
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
USD889655S1 (en) 2018-02-09 2020-07-07 Tepha, Inc. Three dimensional mastopexy implant
USD889654S1 (en) 2018-02-09 2020-07-07 Tepha, Inc. Three dimensional mastopexy implant
USD892329S1 (en) 2018-07-03 2020-08-04 Tepha, Inc. Three dimensional mastopexy implant
US10842612B2 (en) 2015-08-21 2020-11-24 Lifecell Corporation Breast treatment device
US11045579B2 (en) 2016-08-31 2021-06-29 Lifecell Corporation Breast treatment device
WO2022055966A1 (en) 2020-09-09 2022-03-17 Tepha, Inc. Implants and systems for scarless mastopexy
US11298220B2 (en) 2019-05-03 2022-04-12 Lifecell Corporation Breast treatment device
WO2022164779A1 (en) 2021-01-26 2022-08-04 Tepha, Inc. Minimally invasive breast suspension system
US11766321B2 (en) 2019-11-25 2023-09-26 Tepha, Inc. Breast implant wraps to limit movement of breast implants and related methods
US11779455B2 (en) 2018-10-02 2023-10-10 Tepha, Inc. Medical devices to limit movement of breast implants
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair
US12186449B2 (en) 2018-05-03 2025-01-07 Collplant Ltd. Dermal fillers and applications thereof
US12496178B2 (en) 2017-05-02 2025-12-16 Sofradim Production Prosthesis for inguinal hernia repair

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840629A (en) * 1987-10-14 1989-06-20 Silimed Silicone E Instrumental Medico-Cirurgico E Hospitalar Ltda. Mammary prosthesis
FR2682284A1 (en) * 1991-10-14 1993-04-16 Dessapt Bernard Mammary prosthesis
US5217494A (en) * 1989-01-12 1993-06-08 Coggins Peter R Tissue supporting prosthesis
WO1997004722A1 (en) * 1995-07-27 1997-02-13 Pignataro Anthony S Mammary prosthesis and method of surgically implanting same
FR2746298A1 (en) * 1996-03-25 1997-09-26 Bellity Philippe Surgical support prosthesis for human breast
WO2001008515A1 (en) * 1999-08-03 2001-02-08 Antonia Buntz Method for embellishing the shape of a human body by means of a cosmetic plaster

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840629A (en) * 1987-10-14 1989-06-20 Silimed Silicone E Instrumental Medico-Cirurgico E Hospitalar Ltda. Mammary prosthesis
US5217494A (en) * 1989-01-12 1993-06-08 Coggins Peter R Tissue supporting prosthesis
FR2682284A1 (en) * 1991-10-14 1993-04-16 Dessapt Bernard Mammary prosthesis
WO1997004722A1 (en) * 1995-07-27 1997-02-13 Pignataro Anthony S Mammary prosthesis and method of surgically implanting same
FR2746298A1 (en) * 1996-03-25 1997-09-26 Bellity Philippe Surgical support prosthesis for human breast
WO2001008515A1 (en) * 1999-08-03 2001-02-08 Antonia Buntz Method for embellishing the shape of a human body by means of a cosmetic plaster

Cited By (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476249B2 (en) 2004-08-06 2009-01-13 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
US8007531B2 (en) 2004-08-06 2011-08-30 Frank Robert E Implantable prosthesis for positioning and supporting a breast implant
WO2009001293A1 (en) * 2007-06-24 2008-12-31 Gary Pierre Lauryssen Human mammary prosthetic support and method of implanting
JP2010530778A (en) * 2007-06-24 2010-09-16 ピエール ラウリセン，ゲイリー Artificial support for human breast and transplantation method
WO2009039371A1 (en) 2007-09-19 2009-03-26 Ethicon, Inc. Performed support device and method and apparatus for manufacturing the same
US7875074B2 (en) 2007-09-19 2011-01-25 Ethicon, Inc. Naturally contoured, preformed, three dimensional mesh device for breast implant support
EP3335669A2 (en) 2007-09-19 2018-06-20 Ethicon, Inc. Preformed support device and method and apparatus for manufacturing the same
US8101116B2 (en) 2007-09-19 2012-01-24 Ethicon, Inc. Preformed support device and method and apparatus for manufacturing the same
CN105078613A (en) * 2009-07-21 2015-11-25 生命细胞公司 Graft materials for surgical breast procedures
CN105078613B (en) * 2009-07-21 2018-07-20 生命细胞公司 Graft materials for surgical breast operation
US8986377B2 (en) 2009-07-21 2015-03-24 Lifecell Corporation Graft materials for surgical breast procedures
AU2010276354B2 (en) * 2009-07-21 2014-10-02 Lifecell Corporation Graft materials for surgical breast procedures
US10449034B2 (en) 2009-07-21 2019-10-22 Lifecell Corporation Graft materials for surgical breast procedures
WO2011011394A3 (en) * 2009-07-21 2011-03-17 Lifecell Corporation Graft materials for surgical breast procedures
US10835370B2 (en) 2009-07-21 2020-11-17 Lifecell Corporation Graft materials for surgical breast procedures
US11179235B2 (en) 2009-07-21 2021-11-23 Lifecell Corporation Graft materials for surgical breast procedures
US10765507B2 (en) 2011-03-09 2020-09-08 Tepha, Inc. Methods for mastopexy
US9585744B2 (en) 2011-03-09 2017-03-07 Tepha, Inc. Systems and methods for mastopexy
US10258460B2 (en) 2011-03-09 2019-04-16 Tepha, Inc. Systems and methods for mastopexy
US11744696B2 (en) 2011-03-09 2023-09-05 Tepha, Inc. Implants and methods for mastopexy
WO2012131222A2 (en) 2011-03-22 2012-10-04 Edouard Pelissier Implantable medical device for the correction of breast ptosis
US10004590B2 (en) 2012-01-13 2018-06-26 Lifecell Corporation Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses
US10695165B2 (en) 2012-01-13 2020-06-30 Lifecell Corporation Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses
US9549812B2 (en) 2012-01-13 2017-01-24 Lifecell Corporation Breast prostheses, methods of manufacturing breast prostheses, and methods of treatment using breast prostheses
US10039633B2 (en) 2012-06-21 2018-08-07 Lifecell Corporation Implantable prosthesis having acellular tissue attachments
US10959833B2 (en) 2012-06-21 2021-03-30 Lifecell Corporation Implantable prosthesis having acellular tissue attachments
US9956072B2 (en) 2012-10-04 2018-05-01 Lifecell Corporation Surgical template and delivery device
US10058417B2 (en) 2013-07-11 2018-08-28 Tepha, Inc. Absorbable implants for plastic surgery
US11439490B2 (en) 2013-07-11 2022-09-13 Tepha, Inc. Absorbable implants for plastic surgery
US12285325B2 (en) 2013-07-11 2025-04-29 Tepha, Inc. Absorbable implants for plastic surgery
US9655715B2 (en) 2013-07-11 2017-05-23 Tepha, Inc. Absorbable implants for plastic surgery
US10028818B2 (en) 2013-07-11 2018-07-24 Tepha, Inc. Absorbable implants for plastic surgery
US9636211B2 (en) 2013-07-11 2017-05-02 Tepha, Inc. Absorbable implants for plastic surgery
US9532867B2 (en) 2013-07-11 2017-01-03 Tepha, Inc. Absorbable implants for plastic surgery
US10568728B2 (en) 2013-07-11 2020-02-25 Tepha, Inc. Absorbable implants for plastic surgery
EP3622972A1 (en) 2013-07-11 2020-03-18 Tepha, Inc. Absorbable implants for plastic surgery
WO2015006737A1 (en) 2013-07-11 2015-01-15 Tepha, Inc. Absorbable implants for plastic surgery
US10722345B2 (en) 2013-07-11 2020-07-28 Tepha, Inc. Absorbable implants for plastic surgery
WO2016172094A1 (en) 2015-04-23 2016-10-27 Tepha, Inc. Absorbable implants for plastic surgery
US10660741B2 (en) 2015-04-24 2020-05-26 Sofradim Production Prosthesis for supporting a breast structure
US9931198B2 (en) 2015-04-24 2018-04-03 Sofradim Production Prosthesis for supporting a breast structure
US12161547B2 (en) 2015-04-24 2024-12-10 Sofradim Production Prosthesis for supporting a breast structure
US11439498B2 (en) 2015-04-24 2022-09-13 Sofradim Production Prosthesis for supporting a breast structure
US10307237B2 (en) 2015-05-15 2019-06-04 Lifecell Corporation Tissue matrices and methods of treatment
US10842612B2 (en) 2015-08-21 2020-11-24 Lifecell Corporation Breast treatment device
USD927689S1 (en) 2015-10-09 2021-08-10 Tepha, Inc. Three dimensional mastopexy implant
USD985773S1 (en) 2015-10-09 2023-05-09 Tepha, Inc. Three dimensional mastopexy implant
USD836778S1 (en) 2015-10-09 2018-12-25 Tepha, Inc. Three dimensional mastopexy implant
US11045579B2 (en) 2016-08-31 2021-06-29 Lifecell Corporation Breast treatment device
USD816220S1 (en) 2017-04-11 2018-04-24 Tepha, Inc. Three dimensional mastopexy implant
USD816221S1 (en) 2017-04-11 2018-04-24 Tepha, Inc. Three dimensional mastopexy implant
US11672636B2 (en) 2017-05-02 2023-06-13 Sofradim Production Prosthesis for inguinal hernia repair
US12496178B2 (en) 2017-05-02 2025-12-16 Sofradim Production Prosthesis for inguinal hernia repair
US10675137B2 (en) 2017-05-02 2020-06-09 Sofradim Production Prosthesis for inguinal hernia repair
USD889655S1 (en) 2018-02-09 2020-07-07 Tepha, Inc. Three dimensional mastopexy implant
US11833027B2 (en) 2018-02-09 2023-12-05 Tepha, Inc. Full contour breast implant
US11154393B2 (en) 2018-02-09 2021-10-26 Tepha, Inc. Full contour breast implant
USD976407S1 (en) 2018-02-09 2023-01-24 Tepha, Inc. Three dimensional mastopexy implant
WO2019156870A2 (en) 2018-02-09 2019-08-15 Tepha, Inc. Full contour breast implant
USD889654S1 (en) 2018-02-09 2020-07-07 Tepha, Inc. Three dimensional mastopexy implant
EP4529887A2 (en) 2018-02-09 2025-04-02 Tepha, Inc. Full contour breast implant
EP4230178A1 (en) 2018-02-09 2023-08-23 Tepha, Inc. Full contour breast implant
WO2019156870A3 (en) * 2018-02-09 2020-04-23 Tepha, Inc. Full contour breast implant
US11903816B2 (en) 2018-02-09 2024-02-20 Tepha, Inc. Full contour breast implant
US12186449B2 (en) 2018-05-03 2025-01-07 Collplant Ltd. Dermal fillers and applications thereof
USD1040347S1 (en) 2018-07-03 2024-08-27 Tepha, Inc. Three dimensional mastopexy implant
USD892329S1 (en) 2018-07-03 2020-08-04 Tepha, Inc. Three dimensional mastopexy implant
USD977102S1 (en) 2018-07-03 2023-01-31 Tepha, Inc. Three dimensional mastopexy implant
US11779455B2 (en) 2018-10-02 2023-10-10 Tepha, Inc. Medical devices to limit movement of breast implants
US11298220B2 (en) 2019-05-03 2022-04-12 Lifecell Corporation Breast treatment device
US11766321B2 (en) 2019-11-25 2023-09-26 Tepha, Inc. Breast implant wraps to limit movement of breast implants and related methods
US12064330B2 (en) 2020-04-28 2024-08-20 Covidien Lp Implantable prothesis for minimally invasive hernia repair
WO2022055966A1 (en) 2020-09-09 2022-03-17 Tepha, Inc. Implants and systems for scarless mastopexy
EP4647040A2 (en) 2020-09-09 2025-11-12 Tepha, Inc. Implants and systems for scarless mastopexy
WO2022164779A1 (en) 2021-01-26 2022-08-04 Tepha, Inc. Minimally invasive breast suspension system

Similar Documents

Publication Publication Date Title
WO2004096098A1 (en) Prothesis for soft tissue support
US20100191330A1 (en) Human mammary prosthetic support and method of implanting
US11642216B2 (en) Soft tissue repair grafts and processes for preparing and using same
US6464726B1 (en) Breast implant system and method of augmentation
AU2006306193B2 (en) Variable cohesive gel form-stable breast implant
US5820444A (en) Post surgical brassiere
US9913711B2 (en) Internal long term absorbable matrix brassiere
US20180014579A1 (en) Breast cancer post treatment support garment
AU2006242962B2 (en) Soft tissue support
JP6507299B1 (en) bra
US10863779B2 (en) Breast cancer post treatment support garment
EP3056168A1 (en) Breast implant support device with large back surface area
US20210244550A1 (en) Silicone prosthesis provided with elements for attachment and use thereof
US20200107588A1 (en) Post-surgery medical bra garment
WO2002074112A2 (en) Postoperative bilateral augmentation mammaplasty brassiere
WO2019070141A1 (en) Reinforced bra structure and garment for breast compression and support
US12133561B2 (en) Nudity support bra
US20150011140A1 (en) Post-breast surgery brassiere and profile-correcting insert
US20250120456A1 (en) Brassiere ergonomically configured to better support implant-based augmented breasts
US20160338819A1 (en) Breast implant support device with large back surface area
MACR Galactorrhea Following Silicone Breast Implant Placement
JP2021113376A (en) Brassiere
AU2013211528A1 (en) Variable cohesive gel form-stable breast implant

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A DATED 16.01.2006)

122 Ep: pct application non-entry in european phase